Access to Outpatient Longitudinal Drug Utilization Data

U.S. Food and Drug Administration

The buyer seeks access to outpatient longitudinal drug utilization data to enhance drug safety monitoring and analysis. The buyer requires real-time, multi-user access to prescription and patient-level data for analyzing drug exposure, usage patterns, and conducting regulatory impact studies. The data should enable national-level and geographical analysis of outpatient prescriptions and patient counts. The buyer aims to improve post-market risk/benefit analyses and expedite regulatory decision-making processes.

• 12/23/2024 - Release Date
• 1/23/2025 - Proposal Due Date

• Provide real-time, multi-user desktop access to outpatient prescription data
• Offer national-level and geographical counts of outpatient prescriptions over time
• Provide patient-level demographic information linked to prescription data
• Enable characterization of drug exposure duration at patient level
• Allow analysis of concomitant use of drug products at patient level
• Provide national-level estimates of drug utilization patterns using projection methodologies
• Offer HIPAA-compliant data access in a multi-user environment
• Enable downloading of large datasets as needed
• Provide prescriptions and medical claims data
• Maintain ownership of the database and access methods